I have a hunch that Garvis Toler was a huge influence on this deal, Global. Just a hunch is all, based on his background in capital markets. Plus the fact that it's MOR *analytics*. Analytics, being what Garvis has really been focused on.
It sounds like a great shot across the bow of KERN to me. A good response to them. With the $10M, that's like the capital infusion we needed. That's just the amount I said on the time-stamped record that I think woudl be perfect for our needs. I'm so glad that didn't buy someone, like they were talking about as a possibiity when that filing came that raised the authorized share ceiling. Maybe this is what Zac was alluding to in the conference call *prior* to the last one, when he said they were working on that dillutive situation and that retrospect is 20/20. I think he knew the deals got toxic. This could have been that financing he was "hoping to report on" in the last conference call, which didnt' happen. And one of the submitted questions he sidestepped. In fact, he sidestepped all but one or two as I recall. If this was that deal, I can see why he wouldn't really be able to expand on that.
Just don't know what MOR brings to the table. But they must be bringing something if they are going to be 72% of this company. And somebody mentioned somewhere that this comes with no debt, but that's not true. The PR says it comes with no *new debt.* Sounds very exciting.
I do think 21 cents is a good buy. If I didn't have a foot in the door, I'd take a position here for sure. I want to buy back some shares below .20 just out of greed. Anybody?
And with Helix on the Nasdaq, it will get more credibility as you noted. I'd venture to say a lot more comparisons to KERN. And, Ohhhh, I can't wait to go spank Alan, the confused cannabys analyst, once the deal is complete. I have a mouthful and more to say to him when the time is right.
